<DOC>
	<DOCNO>NCT01986660</DOCNO>
	<brief_summary>The purpose study evaluate Ibuprofen Cream ( SST-0225 ) absorb eliminate body define maximum dosing condition evaluate safety condition .</brief_summary>
	<brief_title>Open-Label , Maximum-Dose Pharmacokinetic Study 7.5 % Ibuprofen Cream ( SST-0225 ) Healthy Adults</brief_title>
	<detailed_description />
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Signed consent form Men , woman , 18 55 year Females must pregnant plan become pregnant BMI 18 30 kg/m2 Past nonsmoker High probability compliance completion study Healthy determine investigator base medical history , physical exam , clinical laboratory test , vital sign measurement , ECGs Presence history disorder could interfere completion study Unstable medical condition Surgical medical condition may interfere absorption , distribution , metabolism excretion test drug Positive Hep B , Hep C and/or HIV test Positive urine drug screen Any history skin disorder , include psoriasis , eczema , tattoo , significant scarring , heal wound , skin lesion knee elbow Significant disease Any clinically important deviation normal limit physical exam , vital sign measurement , 12 lead ECG , clinical laboratory test History drug abuse 1 year History alcoholism 1 year Use prescription medication ibuprofen within 30 day Day 1 , use OTC drug , herbal supplement vitamin within 14 day Day 1 . Use investigational drug within 30 day Day 1 Acute disease state within 7 day Day 1 Consumption grapefruit grapefruit containing product within 72 hour Day 1 Tobacco use/caffeine use within 48 hour Day 1</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Pharmacokinetic Study</keyword>
</DOC>